In NOD1-overexpressing (NOD1) cancer cells (Fig. S6A and S6B) treated with HIS-BFT-1 or HIS peptide, BFT-1 was localized at the plasma membrane as detected by immunofluorescence (Fig. 3G). Here, NOD1 is linked to cancer.